News

Completion of the acquisition is subject to customary closing conditions, and is expected to close in the second quarter of 2018. Valchlor® is the first and only FDA-approved

The discovery collaboration is based on a new Regeneron publication in the New England Journal of Medicine identifying for the first time a variant in the HSD17B13 gene

RB ended discussions with Pfizer regarding its proposal, which was for part of the business only. Financial Times reported that GlaxoSmithKline (GSK) is now leading the race for Pfizer's

The partnership will focus on developing three proteins, including tau, TDP-43 and an undisclosed target, implicated in the pathogenesis of various neurodegenerative diseases. Celgene will be provided with

Belimumab and rituximab have different but potentially complementary mechanisms of action. This study will assess whether co-administration enhances the treatment effect of belimumab and provides sustained disease control,

The proposed transaction will be completed pursuant to the acquisition by Cipher of all of the outstanding shares of Cardiome, following a restructuring of Cardiome pursuant to a

Adcetris is an antibody-drug conjugate (ADC) that allows the antibody to direct the drug to a target on lymphoma cells known as CD30, which is considered to be

In a Nature Microbiology paper, the researchers reported that more than a quarter of the non-antibiotics restrict the growth of at least one species in the microbiome, which

Patients receiving the 2 mg dose of etrasimod achieved statistically significant improvements versus placebo in the primary, all secondary, and clinical remission endpoints.  Relative to placebo, there was